Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 13Tumor-Agnostic 8Gastrointestinal 4Genitourinary 3CNS 3Gynecologic 2Sarcoma 1

Conditions

Gliosarcoma 3Glioblastoma 3Brain Neoplasms 3Glioma 2Sarcoma 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 17pembrolizumab 12Doxorubicin 10fludarabine 7Irinotecan 7Blood Specimen Collection 7Temozolomide 6Gemcitabine 6Etoposide 6Radiotherapy 5Ifosfamide 5Carboplatin 5Albumin-Bound Paclitaxel 5tecogalan 4cemiplimab 4Vincristine 4Trabectedin 4Paclitaxel 4Nivolumab 4Filgrastim 4Drug Therapy 4Dexamethasone 4Bevacizumab 4pazopanib 3olaparib 3nilotinib 3dostarlimab 3aflibercept 3Therapeutics 3Taxes 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Lapatinib × Sarcoma × Clear all
NCT00107003 2018-07-05

GW572016 to Treat Recurrent Malignant Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
9 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡